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Abstract
Background: RNA-Seq exploits the rapid generation of gigabases of sequence data by Massively Parallel Nucleotide 
Sequencing, allowing for the mapping and digital quantification of whole transcriptomes. Whilst previous comparisons 
between RNA-Seq and microarrays have been performed at the level of gene expression, in this study we adopt a more 
fine-grained approach. Using RNA samples from a normal human breast epithelial cell line (MCF-10a) and a breast 
cancer cell line (MCF-7), we present a comprehensive comparison between RNA-Seq data generated on the Applied 
Biosystems SOLiD platform and data from Affymetrix Exon 1.0ST arrays. The use of Exon arrays makes it possible to 
assess the performance of RNA-Seq in two key areas: detection of expression at the granularity of individual exons, and 
discovery of transcription outside annotated loci.
Results: We found a high degree of correspondence between the two platforms in terms of exon-level fold changes 
and detection. For example, over 80% of exons detected as expressed in RNA-Seq were also detected on the Exon 
array, and 91% of exons flagged as changing from Absent to Present on at least one platform had fold-changes in the 
same direction. The greatest detection correspondence was seen when the read count threshold at which to flag 
exons Absent in the SOLiD data was set to t<1 suggesting that the background error rate is extremely low in RNA-Seq. 
We also found RNA-Seq more sensitive to detecting differentially expressed exons than the Exon array, reflecting the 
wider dynamic range achievable on the SOLiD platform. In addition, we find significant evidence of novel protein 
coding regions outside known exons, 93% of which map to Exon array probesets, and are able to infer the presence of 
thousands of novel transcripts through the detection of previously unreported exon-exon junctions.
Conclusions: By focusing on exon-level expression, we present the most fine-grained comparison between RNA-Seq 
and microarrays to date. Overall, our study demonstrates that data from a SOLiD RNA-Seq experiment are sufficient to 
generate results comparable to those produced from Affymetrix Exon arrays, even using only a single replicate from 
each platform, and when presented with a large genome.
Background
RNA-Seq technology
Massively Parallel Nucleotide Sequencing (MPNS) allows
the rapid generation of gigabases of sequence data at a
relatively low cost per residue. A variety of platforms
exist, but all rely on the generation of a large number of
relatively short sequences, known as 'tags' or 'reads' that
can then be aligned to a target database, or assembled de
novo into contiguous sequences. In many MPNS experi-
ments, it is possible to treat the set of reads generated
during a sequencing run as an unbiased sampling of the
total nucleotide complement of the cells, making it possi-
ble to use the number of reads aligning to a given locus as
an estimate of its abundance. A major application that
depends on this is RNA-Seq [1-7]. Here, the proportion
of reads matching a given transcript is used as a measure
of its expression level.
Unlike hybridization-based techniques such as qPCR
or microarrays, RNA-Seq does not rely on pre-deter-
mined probes designed against known target sequences,
allowing it to be used to search for novel transcription at
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Page 2 of 12previously uncharacterized loci. Although this can be
achieved successfully using tiling arrays, microarrays can
suffer from binding affinity constraints that make it diffi-
cult to design reliable probes targeted at certain
sequences, rendering parts of the genome inaccessible
[8]. In addition, recent research has revealed extensive
amounts of alternative splicing in the human genome [9],
leading to the prediction that there are many novel tran-
scripts arising from uncharacterized splicing events, and/
or the incorporation of additional exons up- and down-
stream of a given gene. By seeking reads that cross exon-
exon boundaries, MPNS can be used to identify novel
arrangements of exons, and thus, novel transcripts [10].
Although powerful, RNA-Seq is not without challenges,
and many of the computational caveats that apply to
microarray analysis are equally applicable, including an
inability to distinguish between loci with 100% sequence
similarity, and a dependence on appropriate algorithms,
statistics and annotation tools to support the data analy-
sis [11,12]. Critical to the approach is the need to gener-
ate sufficient reads to cover each locus at sufficient depth
to give reliable estimates of expression. This can be signif-
icantly more than might be expected because the
approach relies on random sampling of the fragmented
transcriptome. The wide dynamic range of transcription
data means that a relatively small number of highly
expressed loci can account for the majority of the reads in
the study (in the data that follows, for example, 50% of the
exonic reads map to less than 1% of exons in MCF-10a).
Affymetrix Human Exon 1.0ST arrays
Affymetrix Exon arrays are currently the most dense
arrays designed specifically for profiling gene expression
[13]. They feature approximately 1.2 million probesets
that aim to target every known and predicted exon in the
entire genome, supporting the detection of alternative
splicing events [14,15]. Each probeset consists of up to
four probes targeting a defined probe selection region
(PSR). A PSR can correspond to an exon supported either
by RefSeq mRNA evidence, Expressed Sequence Tag
(EST) evidence or purely computational predictions.
Approximately 50% of probesets target loci outside
Ensembl-defined protein coding exons, allowing Exon
arrays to detect transcription outside well-characterized
loci [16]. In this respect, they share some of the potential
advantages of RNA-Sequencing platforms.
Objectives
Several recent studies have compared gene expression
microarrays with RNA-Seq using both human [6,17] and
mouse [5,7,18] samples, reporting good correspondence
between gene expression and fold changes, and higher
gene detection rates in RNA-Seq than on an array. In this
study, we adopt a more fine-grained approach by compar-
ing RNA-Seq data from an Applied Biosystems (AB)
SOLiD v3 platform to exon-level microarray data pro-
duced using Affymetrix Human Exon 1.0ST arrays.
Unlike the previous studies above, the use of Exon arrays
makes it possible to assess the performance of RNA-Seq
in two key areas: detection of expression at the granular-
ity of individual exons, and discovery of transcription
outside annotated loci. In addition, we leverage the Exon
array data to assess the level of technical background
present in our RNA-Seq dataset, the influence of reads
that map to multiple genomic loci, and to define the fold
change threshold used to call differentially expressed
exons. As such, we do not treat the Exon arrays as a gold
standard but simply as a reliable source of an unknown




RNA from two cell lines, MCF-7, a breast cancer line, and
MCF-10a, a normal epithelial line, was used in this study.
One sample from MCF-10a and two technical replicates
from MCF-7 (labelled MCF-7_r1 and MCF-7_r2) were
analysed on the SOLiD platform (see Methods), and the
same RNA samples hybridised in triplicate to Affymetrix
Exon 1.0ST arrays, as previously described [19]. MCF-7 is
an abnormal and heterogeneous cell-line. Consequently,
sequence differences between its genome and that of the
reference used to design the arrays may result in some
probes failing to hybridise to their target sequence. How-
ever, both MCF-10a and MCF-7 achieve similar probeset
detection rates. These are significantly above the QC
thresholds recommended by the manufacturer, and well
within the bounds that are typical for cell line microarray
data. A low detection rate, which would be indicative of a
substantial number of probesets failing to hybridize suc-
cessfully (as would be expected if genetic instability was a
significant confounding factor), was not observed. Fur-
thermore, similar effects would also cause issues with the
RNA-Seq data, since SNPs and polymorphisms will result
in increased error rates during alignment. Therefore, it is
unlikely that the genomic complexity of MCF-7 would
have a significant effect on these data.
Variability between RNA-Seq replicates was low; high
correspondence was observed at both the exon (r = 0.87;
Additional File 1: Supplementary Figure S1A) and gene
expression levels (r = 0.92; Additional File 1: Supplemen-
tary Figure S1B). For cross platform correspondence, the
Exon array replicate from each cell line with the largest
proportion of detected probesets was selected, together
with the RNA-Seq MCF-7 replicate having the highest
number of reads (MCF-7_r1).
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human genome allowing 6 mismatches per read. Unless
otherwise stated, reads that matched to multiple loci
were removed. Table 1 summarizes the read counts
obtained from each of the sequencing runs. A total of
28,371,318 reads from MCF-10a and 28,882,179 from
MCF-7_r1 mapped uniquely to the genome. 77%
(21,709,397) of these mapped to an Ensembl known tran-
script [20] in MCF-10a and 76% (22,031,344) in MCF-
7_r1, and of these 74% (15,996,190) and 79% (17,439,762)
respectively mapped to a known exon (Figure 1). Overall,
85% (24,159,893) of reads in MCF-10a, and 83%
(23,988,482) in MCF-7_r1 mapped to annotated loci that
included known transcripts, Ensembl Genscan predic-
tions, ESTs, and sequences between the 5'- and 3'-most
probes within each probeset. Over half of all known
exons in both cell lines (58%; 168,678/291,229 in MCF-
10a, and 59%; 170,721/291,229 in MCF-7) featured at
least one matching read.
Determination of background
Estimates of transcript abundance on Exon arrays can be
affected by biases due to cross hybridisation as a result of
probes hybridising to off-target transcripts [8,21]. Like-
wise, RNA-Seq can suffer from reads that align to incor-
rect loci due to sequencing errors, or differences between
the reference sequence and that of the genome under
study. In this work, we define these reads as "back-
ground". In order to quantify background in our RNA-
Seq data, we carried out two analyses. First we considered
genes on the Y chromosome, and secondly, we compared
exon detection on the SOLiD platform with Present/
Absent calls on the Exon Array.
Expression levels on the Y chromosome
Due to its absence in female samples, no RNA should
originate from the Y chromosome in MCF-10a and MCF-
7; any reads uniquely mapping here should therefore be
due to technical artefacts. We therefore measured the
proportion of exons targeted by at least one read in both
MCF-10a and MCF-7. To account for pseudo-autosomal
regions where the probability of mapping a read unam-
biguously is reduced, we only considered exons whose
length exceeded 100 bases after subtracting the number
of non-unique loci (see Methods) found within that exon.
This reduced the total number of exons under consider-
ation by 36% from 1835 to 1178. Only three (0.25%) of
these exons on the Y chromosome in MCF-10a and six
(0.51%) exons in MCF-7 were targeted by at least one
mappable read. Four of these exons from both cell lines
Table 1: Summary of read counts across different genomic locations.
MCF-10a MCF-7_r1 MCF-7_r2
Total 286,197,907 302,129,896 150,762,975
After error filtering 173,966,873 205,050,087 113,512,672
Mappable 47,524,622 46,330,340 33,697,119
Uniquely mappable 28,371,318 28,882,179 22,223,910
Location
Ensembl known
Total 21,709,397 22,031,344 16,980,001
Exon 15,996,190 17,439,762 12,800,399
Intron 5,713,207 4,591,582 4,179,602
All annotation1 24,037,188 23,854,633 18,830,788
Exon Junctions
Known 1,010,785 1,225,448 -
Putative 16,548 23,540 -
1Known, predicted and EST transcripts
Figure 1 Read locations. The proportion of unique reads in (A) MCF-
10a and (B) MCF-7, mapping to four genomic locations: known exons 
and introns, as defined by Ensembl, other annotated regions including 
ESTs, Genscan predictions and Exon array probe selection regions, and 
un-annotated regions.
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derived from two genes (USP9Y and NLGN4Y) with high
sequence identity to corresponding genes (USP9X and
NLGN4X) on the X chromosome. Supplementary Figure
S2 (Additional File 1) shows that the number of exons
expressed on the Y chromosome was significantly lower
than on all other chromosomes. For example, on the X
chromosome, which had the second lowest proportion of
expressed exons, over 50% of exons in both MCF-10a and
MCF-7 were targeted by at least one mappable read.
Exploiting Present/Absent calls on the Exon array
On Exon arrays, probesets with signals separable from
background can be flagged Present (P), or Absent (A)
using the Detection Above Background (DABG) score
[22], which estimates the probability that a probeset's sig-
nal is similar to the general background distribution. The
DABG score is calculated by comparing each probe to a
GC-content matched reference pool of background
probes, and combining these data across the probeset to
yield a final p-value. Any probeset with a p-value below a
pre-defined threshold is flagged Present.
In order to further assess background level in the RNA-
Seq data, we compared P/A calls for the 155,016 exons
targeted by a single probeset on the Exon array with P/A
calls for the same exons on the SOLiD platform, where an
exon was defined as Present if the number of reads map-
ping to it was greater than a threshold t. Since such a
comparison is dependent on the detection threshold used
for each platform, we took an unbiased approach in
which read count and DABG thresholds were varied
independently (Figure 2A). At each combination of
expression level and DABG threshold, we calculated a
correspondence score (CS; see Methods). We initially
considered three DABG p-value cut-offs of 0.1, 0.05 and
0.01 and found that CS was maximal (0.67) at a read
count greater than zero and DABG threshold of 0.01 in
MCF-10a (Figure 2A). For MCF-7, significant correspon-
dence (CS = 0.64) was also seen at these thresholds. At
this read count and DABG threshold in MCF-10a, 87%
(83,133) of the exons called Present on the Exon array
were also called Present using the RNA-Seq data, and
81% (47,925) of the exons called Absent on the array were
also flagged Absent on SOLiD (Figure 2B). We observed
similar results in MCF-7, suggesting that the genetic
instability of this cell line had little impact on detection
rates in both RNA-Seq and on the array: 86% (82,438) of
exons present on the Exon array were Present on SOLiD,
and 78% (45,879) of exons Absent on the Exon array were
also Absent on SOLiD. Furthermore, exons detected
solely by RNA-Seq tended to have a low level of expres-
sion in both cell lines (Additional File 1: Supplementary
Figures S3A and S3B).
We also considered a fourth, more stringent DABG p-
value cut-off of 0.001 at which detection correspondence
was generally higher than at the other DABG thresholds
(Figure 2A). However, at a read count threshold of zero,
CS increased only marginally by 0.002 in MCF-10a from a
DABG cut-off of 0.01 to 0.001, and decreased in MCF-7,
thus failing to compensate for the significant reduction of
probesets called Present on the Exon array (14,833 in
MCF-10a and 16,049 in MCF-7). We also observed that
the maximum CS was achieved in both cell lines at a read
count threshold of one. This result was expected since the
majority (58%; 5424/9301) of exons in MCF-10a with a
single mappable read were called Absent on the array at
this DABG cut-off, compared with only 42% (3885/9301)
at a cut-off of 0.01, thus the read count threshold achiev-
ing maximal CS increases to account for this.
In addition, we also performed the same analysis with
normalised expression values calculated using Equation
2. Supplementary Figure S4 (Additional File 1) shows
similar trends to Figure 2A with the optimal correspon-
dence (with a DABG cut-off of 0.01) occurring at a norm-
alised expression value of 0.3.
Taken together with the low number of reads mapping
to the Y chromosome, these data suggest that the back-
ground error rate is extremely low in RNA-Seq data. We
therefore chose t < 1 as the read count threshold at which
to flag exons Absent in the SOLiD data. In addition, our
results confirm that a DABG cut-off at 0.01 is a sensible
choice to call probesets Present/Absent on the Exon
array.
Expression level and fold change correspondence
Given the differences between the platforms and the pro-
tocols used to prepare their samples, it is perhaps unrea-
sonable to expect significant correlation between their
raw expression levels, although we did see some correla-
tion (r = 0.55, MCF-10a; r = 0.53, MCF-7) for those exons
flagged Present on both platforms (Additional File 1: Sup-
plementary Figures S5A and S5B respectively). However,
fold changes should be consistent across platforms, par-
ticularly for features that have sufficient signal to noise
ratio to yield a reliable fold-change in both arms of the
study. Fold changes between the log2 exon expression lev-
els from MCF-7 and MCF-10a were calculated indepen-
dently for the Exon array and SOLiD platform, and then
compared (Figure 2C). Note that, to avoid taking logs of
zero (a situation that arises in exons without a mappable
read), we added a small constant (0.0001) to all norma-
lised expression levels calculated using Equation 2. This
results in the appearance of three clusters of data in Fig-
ure 2C: the uppermost cluster in which the majority of
data are a result of Absent (zero count) to Present fold
changes in RNA-Seq, the lowermost cluster resulting
from Present to Absent fold changes, and a middle cluster
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fold changes. Fold changes showed good correspondence
(r = 0.59) between platforms when data points featuring
at least one Absent-flagged sample were removed (i.e.
after eliminating comparisons involving data points with
poor signal-noise ratio, essentially all data except the red
points of Figure 2C). The majority (91%; 7077/7757) of
exons flagged as changing from Absent to Present on at
least one platform had fold-changes in the same direc-
tion, but with different magnitudes. This is to be
expected since Absent-flagged exons are likely to have
poor signal to noise ratio, and thus unstable ratios. Those
flagged Absent in both cell lines in at least one platform
showed least correspondence.
Figure 2 Correspondence between RNA-Seq and Exon arrays. (A) Determination of the read count threshold giving optimum correspondence 
between both platforms with respect to Present/Absent calls. (B) Present/Absent call correspondence at a read count threshold of zero in RNA-Seq 
and a DABG score threshold of 0.01 on the array. (C) Comparison of fold changes between RNA-Seq and the array. Red dots indicate exons flagged as 
Present (P) in both samples and on both platforms (PP->PP). Grey dots indicate exons flagged as Absent (A) in at least one sample on both platforms 
(AA->AA, PA->PA, AP->AP, PA-AP, AP->PA, AA->PA, AA->AP, PA->AA, AP->AA). Note that, due to the density of the data, some grey points represent-
ing exons Absent in both RNA-Seq samples (zero fold change) are masked by other colours. Blue dots indicate exons Absent in at least one RNA-Seq 
sample but flagged Present in both array samples (PA->PP, AA->PP, AP->PP), and green dots represent exons Present in both samples in RNA-Seq but 
flagged Absent in at least one sample on the array (PP->PA, PP->AA, PP->AP). (D) Overlap between numbers of exons called differentially expressed 
by the array and RNA-Seq using (Left) a log2 fold change threshold of 2.0 on the array and 3.0 in RNA-Seq (left) and a LIMMA p-value threshold of 1 × 
10-4 on the array and an Audic-Claverie p-value threshold of 1 × 10-7 in RNA-Seq (right). These thresholds lead to the greatest equivalence between 
platforms using an overlap metric based on the CS (Equation 2).
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In these analyses, we removed reads that target multiple
loci. A consequence of this is that paralogous genes with
regions of 100% sequence identity greater than or equal
to the read length may be under-counted, since reads will
not be reported at these sites. Since this might result in
loss of sensitivity for these exons on the RNA-Seq plat-
form, we repeated the above analysis using both unique
and multi-targeting reads. All locations targeted by a read
were considered, for example, if a read targeted two dif-
ferent transcripts then the read counts of both transcripts
would increase by one. As expected, the proportion of
exons from MCF-10a flagged Present on both SOLiD and
the Exon array increased by 2% from 87% (83133) to 89%
(85238), but at a cost of 2297/59045 (4%) exons called
Present on SOLiD but Absent on the Exon array. A slight
reduction in expression level correspondence from r =
0.54 to r = 0.51 was also seen in MCF-10a. Thus, the
indiscriminate addition of reads that target multiple loci
results in reduced correspondence between the two plat-
forms. In addition, hits to the Y chromosome also
increased with 426/1834 (23%) exons in MCF-10a and
399/1834 (22%) exons in MCF-7 having at least one map-
pable read.
Differential expression
A key application of RNA profiling technology is the abil-
ity to reliably call differential expression for well-charac-
terized protein coding exons. Unlike microarrays,
approaches for identifying differential expression in
RNA-Seq data are in their early stages of development,
particularly those that can process only one RNA-Seq
replicate per condition (a situation that is, at least in the
short-term, likely to arise frequently, given the current
high cost of the approach). In this study, we chose two
measures of differential expression for the RNA-Seq
experiment: fold-change and the Poisson-based approach
of Audic-Claverie (AC) [23]. For all microarray compari-
sons, triplicate exon array data were used, and differential
expression was found using LIMMA [24,25].
Our goal was to find a combination of thresholds from
each differential expression measure that maximises cor-
respondence between the RNA-Seq and Exon array data
sets. To do this, we examined the set difference and inter-
section between the exons called differentially expressed
by each platform. The approach assumes that each plat-
form will generate its own independent set of false posi-
tives and negatives, and that although these will result in
less than perfect correspondence, the intersection, which
represents the consensus between both platforms, will be
enriched for true positives. We used CS (Equation 3) as a
metric, as before. Note that by trying to maximise the
correspondence between platforms, we are not treating
the exon arrays as a gold standard but simply as a reliable
source of an unknown and independent set of true posi-
tives against which to try to maximise the overlap.
Thresholds were varied independently for each plat-
form, and CS calculated (Additional File 1: Supplemen-
tary Figures S6A and S6B). The threshold-pair where CS
was maximal was taken as the point at which to perform
comparisons. We found that the highest correspondence
between platforms (CS = 0.49) occurred with a higher
log2 fold change threshold in RNA-Seq (3.0) than the
arrays (2.0; Additional File 1: Supplementary Figure S6A),
suggesting that the SOLiD platform tends to report
higher fold-changes. This is to be expected, since the
lower background (essentially zero) will result in less
fold-change compression (due to the presence of a con-
stant background value in the numerator and denomina-
tor of the ratio calculation). The distribution of fold
changes on the SOLiD platform versus the Exon array is
shown in Supplementary Figure S7 (Additional File 1). At
these thresholds, 6897 exons were called differentially
expressed on both platforms, 2422 exons were called dif-
ferentially expressed on the Exon array only, and 9255
exclusively on SOLiD (Figure 2D).
When statistical measures were considered, the great-
est correspondence (CS = 0.28) was seen at a p-value of 1
× 10-7 on SOLiD and 1 × 10-5 on the Exon array (Addi-
tional File 1: Supplementary Figure S6B), although given
the different methods of deriving the p-values it is diffi-
cult to compare the AC threshold with LIMMA directly.
Nevertheless, at these thresholds, 6664 exons were called
differentially expressed in RNA-Seq only, compared to
3709 on the Exon array, with 2748 exons called differen-
tially expressed on both platforms, further suggesting
that the SOLiD platform is more sensitive to calling dif-
ferential expression than the Exon array (Figure 2D). See
also Supplementary Figure S8 (Additional File 1), which
compares the p-values calculated by LIMMA and AC
back transformed to quantiles on a normal distribution
and signed by the direction of the fold change, making the
differences in the tails of the population particularly
apparent.
Length bias with the AC measure
Many of the statistical tests thus far applied to RNA-Seq
data suffer from length bias [26]. Length bias is expected
under a uniform sampling assumption. Consequently, if
differences in transcript length are not adequately
accounted for, there will be more power to detect differ-
ences in expression for longer transcripts. Simply divid-
ing read counts by exon length does not correct for this
[26], and the use of AC would then be inappropriate since
the data would no longer be Poisson-distributed. To
determine the extent of length bias at the exon level, we
binned exons by length and calculated the proportion
called differentially expressed in each bin for both the
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AC thresholds at which CS is maximal determined in the
previous section. 11% (9412/82821) of all exons in the
RNA-Seq data were called differentially expressed using
AC. When data were stratified by length, 22% (1489/
6755) of exons in the upper quartile (> 239 bases), and 6%
(1326/23750) in the lower quartile (< 119 bases; Addi-
tional File 1: Supplementary Figure S9A) were found to be
differentially expressed. On the Exon array, 8% (6457/
82821) of all exons were called differentially expressed
using LIMMA compared to 9% (591/6755) of those in the
upper quartile, and 7% (1699/23750) in the lower. Thus,
the expected length bias when using AC was observed in
the RNA-Seq data but not the Exon array dataset. No
length bias was seen when fold change was used to define
differential expression (Additional File 1: Supplementary
Figure S9B).
Differential expression using edgeR
Recently, a new differential expression calling algorithm,
edgeR [27], has been proposed, which models count data
using a negative binomial model that can be regarded as
an over-dispersed Poisson model. To calculate differential
expression, edgeR requires only a pair of replicates in one
condition, allowing its use with the single MCF-10a sam-
ple and two MCF-7 replicates of this study. Thus it pro-
vides a useful comparison with the AC measure that uses
only a single sample from each condition. Like the AC
measure, edgeR does not normalise counts for exon
length although total read numbers in each sample are
considered (Equation 5).
Supplementary Figure S10A (Additional File 1) is anal-
ogous to Figure 2C in showing fold change correspon-
dence between RNA-Seq and the Exon array. However, in
this case fold changes in RNA-Seq are calculated by
edgeR (using both MCF-7 replicates) and on the Exon
array by LIMMA (using all three replicates from both cell
lines). As expected, with the additional information pro-
vided by the replicates, correspondence between fold
changes increased significantly from r = 0.59 to r = 0.71
when data points featuring at least one Absent-flagged
exon were removed. As before, we assessed differential
expression calls at various combinations of fold change
thresholds in RNA-Seq and on the Exon array, and again
found the highest correspondence between platforms (CS
= 0.51) at a log2 fold change threshold of 3.0 in RNA-Seq
and 2.0 on the arrays (Additional File 1: Supplementary
Figure S10B). At these thresholds 6939 exons were called
differentially expressed on both platforms, 2555 exons
were called differentially expressed on the Exon array
only, and 8373 exclusively in RNA-Seq (Additional File 1:
Supplementary Figure S10C).
An increase in p-value correlation between RNA-Seq
and the Exon array was also observed with edgeR (r =
0.68; Additional File 1: Supplementary Figure S10D) com-
pared to AC (r = 0.56; Additional File 1: Supplementary
Figure S8). At a p-value threshold of 0.001 on RNA-Seq
and 0.00001 on the Exon array, maximal differential call
correspondence was reached (CS = 0.48; Additional File
1: Supplementary Figure S10E), with 3221 exons called
differentially expressed on both platforms, 2762 exons
called differentially expressed in RNA-Seq only, and 3308
exons called differentially expressed solely on the Exon
array (Additional File 1: Supplementary Figure S10F).
Whilst it is difficult make direct comparisons between
their p-values, the lower p-value required to achieve max-
imal correspondence with edgeR compared to AC sug-
gests that edgeR, used with the parameters given in
Methods, is more conservative in its differential expres-
sion calls.
As with AC, some bias towards calling differential
expression in longer exons was evident. Employing the
same procedure as before and using thresholds of 0.001
on RNA-Seq and 0.00001 on the Exon array, 7% (5983/
83896) of all exons in the RNA-Seq data were called dif-
ferentially expressed using edgeR. When data were strati-
fied by length, 13% (865/6709) of exons in the upper
quartile (> 239 bases), and 4% (918/23762) in the lower
quartile (< 119 bases; Additional File 1: Supplementary
Figure S11) were found to be differentially expressed.
Identification of known and novel splicing events
An advantage of RNA-Seq is the opportunity to charac-
terize splicing events by seeking reads that span exon-
exon junctions [6,28]. An additional 1,010,785 and
1,225,448 reads mapped in the sense orientation to our
data set of 263,574 known exon-exon junctions in MCF-
10a and MCF-7 respectively (only 0.01% of hits mapped
in the antisense direction in both cell lines). As a result,
31% of junctions in both MCF-10a (80,756) and MCF-7
(82,708) were confirmed by at least one unique read. The
majority (67,558) of junctions seen in MCF-10a were also
seen in MCF-7.
Accounting for exon-junction reads increased detec-
tion call correspondence between RNA-Seq and Exon
arrays across both cell lines. CS increased from 0.67 to
0.69 in MCF-10a, and from 0.64 to 0.65 in MCF-7. This
equated to an extra 3178 and 3470 exons called present
on both SOLiD and the Exon array in MCF-10a and
MCF-7 respectively, at the expense of only 1861 and 2076
additional exons called present on SOLiD but absent on
the Exon array.
In order to detect novel splice events, searches were
performed against a database of 5,172,880 putative exon-
exon junctions generated by permuting known exon
sequences within each gene (see Methods). A further
16,548 reads in MCF-10a and 23,540 in MCF-7 mapped
to this dataset, capturing 11,725 and 16,850 novel junc-
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Page 8 of 12tions respectively (1,795 in both cell lines). The majority
of these junctions (9,702 in MCF-10a and 13,613 in MCF-
7) were mapped by a single read, which suggests they rep-
resent rare splicing events. 72 high confidence novel
splice junctions in MCF-10a and 129 in MCF-7 were
mapped to by at least five unique reads with more than
one start site and overlapping the junction by at least 12
nucleotides. Of these, 25 were found in both cell lines. A
list of the high confidence junctions is given as Supple-
mentary Table S1 (Additional File 2).
Identification of novel loci of transcription
Given that 15% and 17% of reads in MCF-10a and MCF-7
respectively mapped to regions on the genome that are
currently un-annotated, we performed a systematic
search to identify which of these regions are likely to rep-
resent novel loci of transcription, focusing in particular
on putative novel exons. To do this, we first grouped
reads into clusters by seeking sets of overlapping reads,
and then merging adjacent clusters separated by 50 bases.
2,061,888 and 1,840,985 such clusters were found in
MCF-10a and MCF-7 respectively. These were then
labelled exonic (if at least one of their nucleotides was
part of a known exon), intronic, predicted exonic (if over-
lapping a Genscan predicted or EST exon) or predicted
intronic. Those that remained were classed as intergenic.
Discovery of putative novel exons with RNA-Seq
Given the low levels of background observed in these
data, it is clear that the majority of these read clusters,
regardless of location, are indicative of real transcription.
This concurs with other studies that have found as much
as 90% of the human genome to be transcribed [9]. How-
ever, not all of these regions will represent protein-coding
mRNA. To identify these, we first sought read clusters
that had expression levels similar to those of existing
exons, and then attempted to find additional functional
validation by using Pfam [29] to search these sequences
against a database of candidate protein domains.
Using the number of reads contributing to a cluster to
indicate the expression level of that locus, we determined
an expression level cut-off for calling novel exons. This
was achieved by using known exonic and intronic read
clusters to define a threshold that maximised the CS
score in Equation 3. We found that a read count of 19 in
MCF-10a and 16 in MCF-7 gave predictions that most
closely matched the existing gene annotation (Additional
File 1: Supplementary Figure S12). 29,508 and 27,008 read
clusters, not previously labelled exonic or predicted
exonic, exceeded the thresholds in MCF-10a and MCF-7
respectively. Whilst the majority of these were part of
known introns (21,574 in MCF-10a and 19,248 in MCF-
7), 4449 (15%) and 4900 (18%) were found in intergenic
regions of MCF-10a and MCF-7 respectively. The
remainder (3485 in MCF-10a and 2860 in MCF-7)
resided in predicted introns.
We chose to focus on the intergenic read clusters for
the domain analysis. Prior to this step, we removed read
clusters in the bottom quartile (<120 base pairs) of the
known exon length distribution, and translated the nucle-
otide sequence corresponding to each of the remaining
read clusters in all three reading frames. Any clusters
containing a stop codon were removed. The remaining
putative protein sequences (120 from MCF-10a and 173
from MCF-7) were scanned for Pfam domains. A total of
28 read clusters contained either a full or partial Pfam
domain: 16 in MCF-10a and 12 in MCF-7, and of these 8
were found at similar loci in both cell lines (Additional
File 1: Supplementary Table S2).
Comparison with Exon arrays
Affymetrix Exon arrays feature many probesets targeting
loci with relatively weak evidence for transcription;
approximately 50% target outside the core Ensembl exon
annotations. We compared the loci predicted from the
RNA-Seq data, with the locations of these non-core
probesets. Of the 4449 intergenic read clusters in MCF-
10a exceeding the read-count cut-off, 2664 (60%) over-
lapped with a probeset target region extended by 300
nucleotides at either end. Of these probesets, 92% (2462/
2664) were called Present. Likewise in MCF-7, 62%
(3038/4900) of read clusters were located at or near a
probeset selection region, and of these, 91% (2767/3038)
were called Present. In general, we found that as the read
count of a cluster increased, the probability of finding a
neighbouring probeset also increased, and that probeset
was more likely to be called Present (Additional File 1:
Supplementary Figure S13). When domain filtering is
included, 26 of the 28 read clusters (93%) in Supplemen-
tary Table S2 (Additional File 1) map to or near probesets,
of which 16 were called Present. This compares favour-
ably with the overlap observed for the core annotations.
Conclusions
The success of a transcript-profiling platform depends on
a number of technical constraints, including sensitivity
and selectivity, its coverage, and its accuracy. These must
be balanced against more pragmatic considerations that
include cost, throughput and ease of data-analysis. Unlike
array-based technologies, the sensitivity and accuracy of
RNA-Seq is highly dependent on having significant reads
to cover the genome with enough detail to provide valid
data for low-abundance transcripts.
In this study we show that data from a SOLiD RNA-Seq
experiment is sufficient to generate results comparable to
those produced from Affymetrix Exon arrays, even using
only a single replicate from each platform, and when pre-
sented with a large genome. In part, this is achievable
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Page 9 of 12only because the RNA-Seq protocols used here preserved
'strandedness' information, allowing comparisons to be
performed in the knowledge of the 5'-3' orientation of
each read. This is likely to be a pre-requisite for many
experiments. Furthermore, the consistency of results
between both cell lines reinforced our original belief that
the genomic complexity of MCF-7 has little impact on the
comparison between RNA-Seq and the Exon array. Our
main focus was at the exon level, and this, to our knowl-
edge, is the first study to present such a fine-grained com-
parison between the two platforms. In addition, it was
possible to identify a set of intergenic loci expressed at
significant levels, the majority (60%) of which match
probesets on the Exon array. Further analysis suggested
that many of them would result in the expression of
known protein-coding domains, if translated, providing
evidence that these are not simply transcriptional arte-
facts. Finally, by searching a dataset of novel exon-exon
junction sequences, we were able to identify thousands of
putative novel splicing events.
Of course, although the data presented here show sig-
nificant technical correspondence between platforms,
this does not obviate the need for replication at the bio-
logical level in order to assess the likelihood that these
changes are simply chance occurrences. Indeed, where
replicate data is available, this information is useful and
can lead to improved performance, as evidenced by the
closer correspondence achieved between the RNA-Seq
and the array data with edgeR and utilising the two MCF-
7 replicates. As technology continues to improve it is rea-
sonable to expect the number of reads generated in a sin-
gle sequencing run to increase substantially, allowing
multiple samples to be processed on a single slide and so
reducing the cost of the experiment dramatically. One
clear benefit of this would be the opportunity to include
an increased number of replicates. As this happens RNA-
Seq will become an increasingly cost-effective approach
to whole transcriptome profiling.
Methods
RNA library preparation
Two cell lines, MCF-7, a breast cancer line, and MCF-
10a, a normal epithelial line, were processed according to
manufacturer's standard protocols. Total RNA (5 μg)
from both cell lines were depleted of 18S and 28S rRNA
and 1 μg of each sample were enzymatically fragmented
using 1 unit of RNase III (Ambion) and incubating at
37°C for 10 minutes. The fragmented RNA was then size
selected using the flashPAGE™ fractionator (Ambion) to
collect RNA fragments ranging in size from ~50-150
nucleotides in length. The RNA fragments were then
ligated to adaptors, converted into cDNA and amplified
by 15 cycles of PCR using the SOLiD™ Small RNA
Expression Kit (Ambion). The PCR reactions were puri-
fied using the Qiagen Minelute PCR purification kit and
separated on a native Novex 6% TBE polyacrylamide gel
(Invitrogen) and stained with SYBR gold. PCR products
ranging in size from ~150-200 bp (corresponding to RNA
fragment insert sizes of ~60-110 nucleotides) were cut
out of the gel, the gel slices were shredded and the prod-
ucts eluted overnight and precipitated. The gel-purified
material was quantitated by nanodrop and prepared for
emulsion PCR and SOLiD sequencing.
Genome level alignments and annotation
Reads of length 50 bases originating from each sample
were first aligned to the human genome (US National
Center for Biotechnology Information (NCBI) Build 36.3)
using Applied Biosystems' SOLiD™ System Analysis Pipe-
line Tool (Corona Lite; http://solidsoftwaretools.com/gf/
project/corona/). Six mismatches were tolerated as rec-
ommended by the Corona documentation, and reads
with an expected error rate (Equation 1) greater than 6
were discarded prior to matching.
where n is the base position in the read and p repre-
sents the predicted probability that the colour call at posi-
tion n is incorrect. p is calculated from the Quality Value
(QV) of the colour call where QV = -10log10(p). Filtering
in this way removes 39% of the reads from MCF-10a, 32%
from MCF-7_r1 and 25% from MCF-7_r2, whilst retain-
ing 94%, 94% and 97% of the uniquely mappable reads
respectively.
Reads that matched multiple loci were removed from
the analysis and the resultant alignment files pre-pro-
cessed to generate 'pile-ups' against each chromosome. In
total, 47,524,622, 46,330,340 and 33,697,119 reads
(including those matching at multiple loci) were mapped
to the genome in MCF-10a, MCF-7_r1 and MCF7_r2
respectively, and of these, 28,371,318, 28,882,179 and
22,223,910 were uniquely mappable to the genome. Once
data were aligned to the genome, the BioConductor pack-
age exonmap and associated annotation database, X:Map
[16] based on Ensembl version 52, were used to group
reads according to the exons, transcripts and genes they
mapped to. These groupings were then used to inform
subsequent statistical analysis. For cross-platform corre-
spondence, we only considered exons targeted by a single
probeset; consequently 155,016 exons were used in the
comparison.
Exon-exon junctions
We anticipated that some of the reads that did not map
contiguously to the human genome would align to exon-
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Page 10 of 12exon junctions, therefore, additional searches were per-
formed against a dataset of 263,574 known exon-exon
junctions as defined by Ensembl version 52. To ensure
that a 50 base read mapped to a splice junction, only the
last 49 bases of the first exon and the first 49 bases of the
second exon were considered (if the exon exceeded
length 49). Reads that matched to more than one junction
loci, or elsewhere on the genome were discarded, result-
ing in 1,010,785 and 1,225,448 reads mapping uniquely to
exon-exon junctions in MCF-10a and MCF-7_r1 respec-
tively.
In order to detect novel splicing events, we generated a
dataset of 5,172,880 novel splice junctions by permuting
known exons within each gene. Again, exons of length
greater than 49 bases were truncated so the length of
each exon pair never exceeded 98 nucleotides. A total of
16,548 and 23,540 reads (that had thus far not been
mapped to either the genome or a known exon-exon
junction) in MCF-10a and MCF-7 respectively mapped
to this novel splice junction dataset. Note that, unless
otherwise stated, splice junction reads were not included
in detection call correspondence or the expression level
calculation (Equation 2).
Measurement of expression level
We adapted the RPKM measure of [5] to calculate a nor-
malized expression level (E) based on the read count
across the region of interest (such as an exon):
where S is the number of reads mapping to the region, L
is the region length, U is the number of non-unique loci
across the exon (see below), T corresponds to the total
number of uniquely mappable reads in each cell line, and
C is a constant set to 1 × 109 in this study. To avoid taking
logs of zero, we added a small constant (0.0001) to all nor-
malised expression levels.
Correspondence Score
To measure Present/Absent correspondence between
RNA-Seq and Exon array technologies we used a modi-
fied version of the Matthew's Correlation Coefficient [30]
to calculate a correspondence score, CS:
where A indicates the number of exons Present on both
platforms, B indicates the number of exons Absent on
both platforms, C indicates the number of exons Present
in the RNA-Seq data but Absent on the Exon array, and D
indicates the number of exons Absent in RNA-Seq but
Present on the Exon array. A CS of -1 means that all exons
called Present in RNA-Seq are called Absent on the Exon
array and vice versa, a CS of zero means that correspon-
dence is no better than random, and a CS of 1 indicates
perfect correspondence.
We also use Equation 3 to measure correspondence
between sets of exons called differentially expressed in
RNA-Seq versus the Exon array at different thresholds. In
this case, A indicates the number of exons called differen-
tially expressed on both platforms, B indicates the num-
ber of exons called unchanging on both platforms, C
represents the number of exons called differentially
expressed in the RNA-Seq data but not the Exon array
and D represents the number of exons called unchanging
in RNA-Seq but differentially expressed on the Exon
array.
Likewise, to identify the optimal threshold (t) for defin-
ing exonic read clusters, we adapted Equation 3 so that A
represents the number of exonic read clusters achieving a
read count greater than t, B indicates the number of
intronic read clusters achieving a read count less than t, C
indicates the number of exonic read clusters achieving a
read count less than t, and D indicates the number of
intronic read clusters achieving a read count greater than
t.
Statistical tests for differential expression
Audic-Claverie
The statistical test of Audic-Claverie [23] was used to
define exon differential expression between the two cell
lines. Audic-Claverie is a model based on Poisson statis-
tics, and has been previously applied to SAGE [31] and
RNA-Seq [6] expression data. The statistic is calculated
according Equation 3.
where x indicates the number of reads across an exon in
MCF-10a, y indicates the number of reads across the cor-
responding exon in MCF-7, and N1 and N2 represent the
total numbers of unique reads in MCF-10a and MCF-7
respectively. In this case, the p-value indicates the proba-
bility of obtaining y counts in MCF-7 given x counts in
MCF-10a.
edgeR
A recently published Bioconductor [32] package, edgeR
[27], was also used to measure exon differential expres-
sion between the two cell lines. It models count data as
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Page 11 of 12employs an empirical Bayes procedure to moderate the
degree of over-dispersion across the exons.
for exon e and sample i, and where Mi is the library size,
ϕg is the dispersion, and pgj is the relative abundance of
exon e in experimental group j to which sample i belongs.
For our purposes, we used tag-wise dispersion with the
smoothing parameter, prior.n, set to 10. Library sizes
were set to the total number of reads in each sample.
Non-unique loci identification
There are a significant number of positions where, for a
given 50-base sequence, one or more identical 50-mers
are found elsewhere on the genome. At these loci, the
probability of finding a uniquely-mappable read given our
six mis-match tolerance is lower than at other positions,
possibly preventing the detection of expression at these
sites. We therefore performed an exhaustive all-against-
all search for all non-unique 50-mers in the genome and
recorded where they matched against the reference. In
detail, starting from each base position on a chromosome
we took a 50 base region of consecutive sequence and
searched for an identical 50 base match elsewhere on the
genome. If one or more matches were found then that
base position and all start positions of the matches were
marked with a "1", otherwise the base position was
marked with "0". In this way, a profile of ones (corre-
sponding to non-unique loci) and zeros (unique-loci) was
generated for each chromosome. 6% of genomic loci were
defined as non-unique using these criteria.
Additional material
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